To follow-up on the therapeutic utility of ACAT inhibition in HCC, it was important to evaluate whether this strategy could also rescue responses from tumour-infiltrating leucocytes (TIL), which are subject to multiple local inhibitory mechanisms. Here, ACAT1 is linked to neoplasm.